Philip Lee

Philip Lee is the Chief Executive Officer at GeneFab, a company focused on contract research, development, and manufacturing in the cell and gene therapy field. He assumed this role in August 2023 after resigning as the Chief Technology Officer at Senti Biosciences, where he was also a co-founder.123 Lee holds a Ph.D. in Bioengineering from the University of California, Berkeley, and has over 20 years of experience in the life sciences industry, particularly in technology innovation and entrepreneurship.34

Before joining GeneFab, Lee held various leadership positions, including Chief Operating Officer and Chief Technology Officer at Senti Biosciences, where he contributed to raising significant capital and leading technical operations.3 He was also the co-founder and CEO of CellASIC, where he pioneered microfluidic cell culture systems.4 His expertise spans synthetic biology, product development, business strategy, and team management.34